Metrogyl 10 mg/g gel Moldóva - rúmenska - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

metrogyl 10 mg/g gel

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd.) - metronidazolum - gel - 10 mg/g

Metrogyl 5 mg/ml soluţie perfuzabilă Moldóva - rúmenska - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

metrogyl 5 mg/ml soluţie perfuzabilă

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd.) - metronidazolum - soluţie perfuzabilă - 5 mg/ml

PRESTANCE 5 mg/5 mg Rúmenía - rúmenska - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prestance 5 mg/5 mg

les laboratoires servier industrie - franta - combinatii (perindoprilum+amlodipinum) - compr. - 5mg/5mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si blocante ale canalelor de calciu

bOPV suspensie orala 20 doze (0,1 ml/doza) Moldóva - rúmenska - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

bopv suspensie orala 20 doze (0,1 ml/doza)

sanofi pasteur sa - vaccin poliomielitic bivalent de sfat 1 ?am 3 (viu atenuat) - suspensie orala - 20 doze (0,1 ml/doza)

Arixtra solutie injectabila in seringa preumpluta 2,5 mg/0,5 ml Moldóva - rúmenska - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

arixtra solutie injectabila in seringa preumpluta 2,5 mg/0,5 ml

aspen pharma trading limited - fondaparinuxum de sodiu - solutie injectabila in seringa preumpluta - 2,5 mg/0,5 ml

Clopidogrel Acino Evrópusambandið - rúmenska - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agenți antitrombotici - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) Evrópusambandið - rúmenska - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid zentiva (previously duocover)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - agenți antitrombotici - coronarian acut miocardic syndromemyocardial.